Is this the fabled 6th indication? I assume it is. We were told it was a neurological condition. The resolution with the university of Munster allowed it to progress to a n=6 trial possibly later this year.
Ann: afamelanotide in fair-skinned Parkinsons patients, page-11
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.99 |
Change
-0.490(3.38%) |
Mkt cap ! $700.3M | |||
| Open | High | Low | Value | Volume |
| $14.30 | $14.49 | $13.89 | $1.370M | 97.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1509 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.05 | 197 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |